Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhythm Psychophysics With Parkinson's Patients
NCT07647913Not yet recruiting
- Sponsor
- McMaster University
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of levodopa in Parkinson's disease (PD), sponsored by McMaster University. Primary endpoints: Changes in mean inter-tap intervals following Levodopa withdrawal during rhythmic tapping tasks at 1 week, Changes in constant error following Levodopa withdrawal during rhythmic tapping tasks at 1 week and 1 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07647913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07647913.